Coherus Management to Participate in the 2024 Citi Global Healthcare Conference
Coherus Management to Participate in the 2024 Citi Global Healthcare Conference
REDWOOD CITY, Calif., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. ("Coherus," NASDAQ: CHRS) today announced that senior management will participate in the 2024 Citi Global Healthcare Conference, with Dr. Theresa LaVallee, Chief Development Officer, sitting on the Novel Mechanisms in Oncology Panel on December 3, 2024, at 3:15 p.m. ET.
加利福尼亚州红木城，2024年11月27日（全球新闻通讯）-- Coherus BioSciences, Inc.（"Coherus," 纳斯达克: CHRS）今天宣布，公司的高级管理层将参加2024年花旗全球医疗会议，首席发展官特蕾莎·拉瓦利博士将于2024年12月3日下午3:15参与肿瘤学新机制小组讨论。
The panel discussion will be accessible via webcast through a link on the Investor Events and Presentations section of the Coherus website: .
小组讨论将通过Coherus网站投资者活动和演示部分的链接进行网络直播。
Coherus Contact Information:
For Investors:
Jodi Sievers
VP, Investor Relations & Corporate Communications
IR@coherus.com
Coherus联系信息:
对于投资者：
乔迪·西弗斯
VP，投资者关系和企业通讯
ir@coherus.com
